Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the latest options here.

The first patient was enrolled this month in a Nanostics-sponsored clinical utility study in Calgary to quantify the impact of incorporating ClarityDX Prostate into the standard of care for the ...

Mr Bailey said a recent prostate cancer death prompted him to get tested. Inviting the Mail as he underwent a PSA test, the Zambia-born former RAF wing commander said: 'I think sadly, with the ...

Prostate cancer is one of the most common types of cancer that affects men. Understanding what it is, who is at risk and how ...

HealthDay News — A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in patients ...